Balancing inflammation: The link between Th17 and regulatory T cells

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Diller, Maggie L ^a   Kudchadkar, Ragini R ^b   Delman, Keith A ^b   Lawson, David H ^b   Ford, Mandy L ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CELL PLASTICITY; CELL TRANSDIFFERENTIATION; EPIGENETICS; HUMAN; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; METABOLISM; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY;

ANIMALS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84978698951     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/6309219     Document Type: Review

References (69)

1. R. V. Luckheeram, R. Zhou, A. D. Verma, and B. Xia, "CD4+T cells: differentiation and functions, " Clinical and Developmental Immunology, vol. 2012, Article ID 925135, 12 pages, 2012.
2. L. Zhou, M. M. W. Chong, and D. R. Littman, "Plasticity of CD4+ T Cell Lineage Differentiation, " Immunity, vol. 30, no. 5, pp. 646-655, 2009.
3. L. Zhou, J. E. Lopes, M. M. W. Chong, et al., "TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function, " Nature, vol. 453, no. 7192, pp. 236-240, 2008.
4. K. S. Voo, Y. Wang, F. R. Santori, et al., "Identification of IL-17-producing FOXP3+ regulatory T cells in humans, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4793-4798, 2009.
5. Y. K. Lee, R. Mukasa, R. D. Hatton, and C. T. Weaver, "Developmental plasticity of Th17 and Treg cells, " Current Opinion in Immunology, vol. 21, no. 3, pp. 274-280, 2009.
6. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, "TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, " Immunity, vol. 24, no. 2, pp. 179-189, 2006.
7. P. R. Mangan, L. E. Harrington, D. B. OQuinn, et al., "Transforming growth factor-β induces development of the TH17 lineage, " Nature, vol. 441, no. 7090, pp. 231-234, 2006.
8. E. Bettelli, Y. Carrier, W. Gao, et al., "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, " Nature, vol. 441, no. 7090, pp. 235-238, 2006.
9. I. I. Ivanov, B. S. McKenzie, L. Zhou, et al., "The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells, " Cell, vol. 126, no. 6, pp. 1121-1133, 2006.
10. W. Chen, W. Jin, N. Hardegen, et al., "Conversion of peripheral CD4+CD25-naive T Cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3, " Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875-1886, 2003.
11. C. L. Langrish, Y. Chen, W. M. Blumenschein, et al., "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, " The Journal of Experimental Medicine, vol. 201, no. 2, pp. 233-240, 2005.
12. L. Yang, D. E. Anderson, C. Baecher-Allan, et al., "IL-21 and TGF-β are required for differentiation of human TH17 cells, " Nature, vol. 454, no. 7202, pp. 350-352, 2008.
13. L. Yang, D. E. Anderson, C. Baecher-Allan, et al., "IL-21 and TGF-bgr are required for differentiation of human TH17 cells, " Nature, vol. 454, no. 7202, pp. 350-352, 2008.
14. T. Korn, E. Bettelli, W. Gao, et al., "IL-21 initiates an alternative pathway to induce proinflammatory T H17 cells, " Nature, vol. 448, no. 7152, pp. 484-487, 2007.
15. J. Barbi, D. Pardoll, and F. Pan, "Metabolic control of the Treg/Th17 axis, " Immunological Reviews, vol. 252, no. 1, pp. 52-77, 2013.
16. R. Wang and D. R. Green, "The immune diet: meeting the metabolic demands of lymphocyte activation, " F1000 Biology Reports, vol. 4, article 9, 2012.
17. R. Wang and D. R. Green, "Metabolic reprogramming and metabolic dependency in T cells, " Immunological Reviews, vol. 249, no. 1, pp. 14-26, 2012.
18. K. Yang and H. Chi, "mTOR and metabolic pathways in T cell quiescence and functional activation, " Seminars in Immunology, vol. 24, no. 6, pp. 421-428, 2012.
19. A. T. Waickman and J. D. Powell, "mTOR, metabolism, and the regulation of T-cell differentiation and function, " Immunological Reviews, vol. 249, no. 1, pp. 43-58, 2012.
20. H. Chi, "Regulation and function of mTOR signalling in T cell fate decisions, " Nature Reviews Immunology, vol. 12, no. 5, pp. 325-338, 2012.
21. J. Kang, S. J. Huddleston, J. M. Fraser, and A. Khoruts, "De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade ofmTOR, " Journal of Leukocyte Biology, vol. 83, no. 5, pp. 1230-1239, 2008.
22. M. Battaglia, A. Stabilini, and M.-G. Roncarolo, "Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells, " Blood, vol. 105, no. 12, pp. 4743-4748, 2005.
23. J. D. Powell, K. N. Pollizzi, E. B. Heikamp, and M. R. Horton, "Regulation of immune responses bymTOR, " Annual Review of Immunology, vol. 30, pp. 39-68, 2012.
24. K. W. Kim, B. H. Chung, B.-M. Kim, M.-L. Cho, and C. W. Yang, "The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients, " Immunology, vol. 144, no. 1, pp. 68-78, 2015.
25. Y. Kurebayashi, S. Nagai, A. Ikejiri, et al., "PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ, " Cell Reports, vol. 1, no. 4, pp. 360-373, 2012.
26. G. M. Delgoffe, K. N. Pollizzi, A. T. Waickman, et al., "Thekinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling bymTORC1 andmTORC2, " Nature Immunology, vol. 12, no. 4, pp. 295-304, 2011.
27. V. Nizet and R. S. Johnson, "Interdependence of hypoxic and innate immune responses, " Nature Reviews Immunology, vol. 9, no. 9, pp. 609-617, 2009.
28. L. Z. Shi, R. Wang, G. Huang, et al., "HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells, " The Journal of Experimental Medicine, vol. 208, no. 7, pp. 1367-1376, 2011.
29. E. V. Dang, J. Barbi, H.-Y. Yang, et al., "Control of TH17/T(reg) balance by hypoxia-inducible factor 1, " Cell, vol. 146, no. 5, pp. 772-784, 2011.
30. H. Wang, H. Flach, M. Onizawa, L. Wei, M. T. Mcmanus, and A. Weiss, "Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210, " Nature Immunology, vol. 15, no. 4, pp. 393-401, 2014.
31. B. V. Park and F. Pan, "Therole of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases, " Cellular & Molecular Immunology, vol. 12, no. 5, pp. 533-542, 2015.
32. M. Veldhoen, K. Hirota, A. M. Westendorf, et al., "The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins, " Nature, vol. 453, no. 7191, pp. 106-109, 2008.
33. A. Kimura, T. Naka, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto, "Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 28, pp. 9721-9726, 2008.
34. F. J. Quintana, A. S. Basso, A. H. Iglesias, et al., "Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor, " Nature, vol. 453, no. 7191, pp. 65-71, 2008.
35. C. B. Wilson, E. Rowell, and M. Sekimata, "Epigenetic control of T-helper-cell differentiation, " Nature Reviews Immunology, vol. 9, no. 2, pp. 91-105, 2009.
36. T. Caza and S. Landas, "Functional and phenotypic plasticity of CD4+ T cell subsets, " BioMed Research International, vol. 2015, Article ID 521957, 13 pages, 2015.
37. G. Wei, L. Wei, J. Zhu, et al., "Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells, " Immunity, vol. 30, no. 1, pp. 155-167, 2009.
38. C. J. Cohen, S. Q. Crome, K. G. MacDonald, E. L. Dai, D. L. Mager, and M. K. Levings, "Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci, " The Journal of Immunology, vol. 187, no. 11, pp. 5615-5626, 2011.
39. B.-H. Yang, S. Floess, S. Hagemann, et al., "Development of a unique epigenetic signature during in vivo Th17 differentiation, " Nucleic Acids Research, vol. 43, no. 3, pp. 1537-1548, 2015.
40. Y. P. Rubtsov, R. E. Niec, S. Josefowicz, et al., "Stability of the regulatory T cell lineage in vivo, " Science, vol. 329, no. 5999, pp. 1667-1671, 2010.
41. T. Miyao, S. Floess, R. Setoguchi, et al., "Plasticity of Foxp3+ T cells reflects promiscuous foxp3 expression in conventional T cells but not reprogramming of regulatory T cells, " Immunity, vol. 36, no. 2, pp. 262-275, 2012.
42. X. Zhou, S. L. Bailey-Bucktrout, L. T. Jeker, et al., "Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, " Nature Immunology, vol. 10, no. 9, pp. 1000-1007, 2009.
43. S. Sakaguchi, D. A. A. Vignali, A. Y. Rudensky, R. E. Niec, and H. Waldmann, "The plasticity and stability of regulatory T cells, " Nature Reviews Immunology, vol. 13, no. 6, pp. 461-467, 2013.
44. A. Laurence, C. M. Tato, T. S. Davidson, et al., "Interleukin signaling via STAT5 constrains T helper 17 cell generation, " Immunity, vol. 26, no. 3, pp. 371-381, 2007.
45. B. Stockinger, "Good for Goose, but not for Gander: IL-2 interferes withTh17 differentiation, " Immunity, vol. 26, no. 3, pp. 278-279, 2007.
46. S. G. Zheng, J. Wang, and D. A. Horwitz, "Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6, " Journal of Immunology, vol. 180, no. 11, pp. 7112-7116, 2008.
47. A. Amadi-Obi, C.-R. Yu, X. Liu, et al., "TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1, " Nature Medicine, vol. 13, no. 6, pp. 711-718, 2007.
48. M. Diller, R. Kudchadkar, K. Delman, D. Lawson, and M. Ford, "Complete response to high dose IL-2 (HDIL-2) and enhanced IFNγ+Th17:TREG ratio in a melanoma patient, " In press.
49. F. Deknuydt, G. Bioley, D. Valmori, and M. Ayyoub, "IL-1γ and IL-2 convert human Treg into TH17 cells, " Clinical Immunology, vol. 131, no. 2, pp. 298-307, 2009.
50. N. Komatsu, K. Okamoto, S. Sawa, et al., "Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis, " Nature Medicine, vol. 20, no. 1, pp. 62-68, 2014.
51. N. Gagliani, M. C. Vesely, A. Iseppon, et al., "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation, " Nature, vol. 523, no. 7559, pp. 221-225, 2015.
52. E. Bettelli, T. Korn, M. Oukka, and V. K. Kuchroo, "Induction and effector functions of TH17 cells, " Nature, vol. 453, no. 7198, pp. 1051-1057, 2008.
53. I. A. Ferber, S. Brocke, C. Taylor-Edwards, et al., "Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE), " The Journal of Immunology, vol. 156, no. 1, pp. 5-7, 1996.
54. R. Chadha, S. Heidt, N. D. Jones, and K. J. Wood, "Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance?" Transplantation, vol. 91, no. 9, pp. 939-945, 2011.
55. C. A. Murphy, C. L. Langrish, Y. Chen, et al., "Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation, " The Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951-1957, 2003.
56. M. Chabaud, J. M. Durand, N. Buchs, et al., "Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, " Arthritis & Rheumatism, vol. 42, no. 5, pp. 963-970, 1999.
57. C. Lock, G. Hermans, R. Pedotti, et al., "Gene-microarray analysis ofmultiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, " Nature Medicine, vol. 8, no. 5, pp. 500-508, 2002.
58. W. Wang, S. Shao, Z. Jiao, M. Guo, H. Xu, and S. Wang, "The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis, " Rheumatology International, vol. 32, no. 4, pp. 887-893, 2012.
59. S. Yoshida, A. Haque, T. Mizobuchi, et al., "Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well healed lung transplants, " American Journal of Transplantation, vol. 6, no. 4, pp. 724-735, 2006.
60. F. S. Benghiat, L. M. Charbonnier, B. Vokaer, V. D. Wilde, and A. L. Moine, "Interleukin 17-producing T helper cells in alloimmunity, " Transplantation Reviews, vol. 23, no. 1, pp. 11-18, 2009.
61. B. E. Burrell and D. K. Bishop, "Th17 cells and transplant acceptance, " Transplantation, vol. 90, no. 9, pp. 945-948, 2010.
62. J. Yuan, J. Bagley, and J. Iacomini, "Hyperlipidemia promotes anti-donor Th17 responses that accelerate allograft rejection, " American Journal of Transplantation, vol. 15, no. 9, pp. 2336-2345, 2015.
63. S. Heidt, D. S. Segundo, and K. J. Wood, "The impact of TH17 cells on transplant rejection and the induction of tolerance, " Current Opinion in Organ Transplantation, vol. 15, no. 4, pp. 456-461, 2010.
64. W. Zou and N. P. Restifo, "TH17 cells in tumour immunity and immunotherapy, "Nature Reviews Immunology, vol. 10, no. 4, pp. 248-256, 2010.
65. F. Martin, L. Apetoh, and F. Ghiringhelli, "Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?" Trends in Molecular Medicine, vol. 18, no. 12, pp. 742-749, 2012.
66. S. R. Bailey, M. H. Nelson, R. A. Himes, Z. Li, S. Mehrotra, and C. M. Paulos, "Th17 cells in cancer: the ultimate identity crisis, " Frontiers in Immunology, vol. 5, article 276, 2014.
67. D. He, H. Li, N. Yusuf, et al., "IL-17 mediated inflammation promotes tumor growth and progression in the skin, " PLoS ONE, vol. 7, no. 2, Article ID e32126, 2012.
68. P. Muranski, A. Boni, P. A. Antony, et al., "Tumor-specific Th17-polarized cells eradicate large established melanoma, " Blood, vol. 112, no. 2, pp. 362-373, 2008.
69. J. S. Kim, T. Sklarz, L. B. Banks, et al., "Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways, " Nature Immunology, vol. 14, no. 6, pp. 611-618, 2013.